FELSHER STEVEN G 4
4 · Modular Medical, Inc. · Filed Jul 2, 2026
Research Summary
AI-generated summary of this filing
Modular Medical (MODD) Director Steven Felsher Receives Award
What Happened
Steven G. Felsher, a director of Modular Medical, received director compensation on June 30, 2026: 25 shares of common stock issued and a derivative award corresponding to 250 shares (an option) granted. No exercise prices or total dollar values are reported (prices shown as N/A), and the option was fully vested and exercisable on the grant date. These awards are compensation, not open-market purchases or sales.
Key Details
- Transaction date: 2026-06-30; Form 4 filed: 2026-07-02 (appears timely — within two business days).
- Securities: 25 shares (issued) and a derivative grant for 250 shares (option). Prices/values: N/A in the filing.
- Post-transaction total holdings: not specified in the provided filing details.
- Footnotes of note:
- F1: Shares issued under the Issuer's Outside Director Compensation Plan.
- F2: Share amounts reflect a 1-for-30 reverse split effective March 31, 2026.
- F3: The option was granted under the Outside Director Compensation Plan and was fully vested and exercisable on the grant date.
- F4: Column 9 on the Form reports beneficial ownership of the class of derivative security; different-option terms are reported separately.
Context
This was a routine director compensation award (an equity grant plus a vested option), not a purchase or sale in the open market. The option was granted already vested and exercisable but was not reported as exercised or sold in this filing. Director awards are common compensation and do not by themselves indicate an insider buying or selling shares for investment reasons.
Insider Transaction Report
- Award
Common Stock
[F1][F2]2026-06-30+25→ 8,498 total - Award
Option to purchase common stock
[F2][F3][F4]2026-06-30+250→ 250 totalExercise: $4.88From: 2026-06-30Exp: 2036-06-30→ Common Stock (250 underlying)
Footnotes (4)
- [F1]These shares were issued to the Reporting Person pursuant to the Issuer's Outside Director Compensation Plan.
- [F2]Share amount reflects the impact of a 1-for-30 reverse stock split of the Issuer's common stock effected on March 31, 2026.
- [F3]The option was granted to the Reporting Person in accordance with the Issuer's Outside Director Compensation Plan, and the option was fully vested and exercisable on the grant date.
- [F4]In accordance with Instruction 4 to this Form, column 9 reports only total beneficial ownership of the "class" of derivative security reported in column 1. Options that have different exercise prices or vesting terms are not considered to be of the same "class."